Industry
Pearson/Clinical Assessment
Total Trials
4
Recruiting
0
Active
0
Completed
3
Success Rate
75.0%-12% vs avg
Key Highlights
Risk & Performance
Pipeline Risk Assessment
Pipeline Risk Assessment
Based on historical performance
High Risk
Score: 65/100
Failure Rate
25.0%
1 terminated/withdrawn out of 4 trials
Success Rate
75.0%
-11.5% vs industry average
Late-Stage Pipeline
0%
0 trials in Phase 3/4
Results Transparency
67%
2 of 3 completed trials have results
Key Signals
2 with results
Enrollment Performance
Analytics
N/A
2(66.7%)
Phase 1
1(33.3%)
3Total
N/A(2)
Phase 1(1)
Activity Timeline
Global Presence
Loading network data...
Clinical Trials (4)
Showing 4 of 4 trials
NCT02286817Phase 1Completed
Phase I Single Dose, Open-Label Pharmacokinetic Study and Single-Blind, Placebo-Controlled Dose Escalation Study of NFC-1 in Adolescents With Attention-Deficit Hyperactivity Disorder
Role: collaborator
NCT02094612Not ApplicableTerminated
Effectiveness of the Quotient® ADHD Assessment in a System of Care
Role: collaborator
NCT02693275Not ApplicableCompleted
Reference Database Development for the Quotient® System iPad Test
Role: lead
NCT02025647Completed
An Evaluation of Innerview™, a Web-based Tool to Support the Integration of Mental Health in the Primary Care Setting
Role: lead
All 4 trials loaded